newsfilter.io
Interview, Fireside Chat

Judge: I might have to block OpenAI going for-profit in expedited trial (Rose Chan Loui explains)

  • An expedited trial regarding the public interest aspect of the conversion is scheduled for autumn later this year.
  • The judge anticipates balancing public interest against the billionaire dispute and may be seeking to engage attorneys general to enforce protective conditions.
  • Legal standing for Elon Musk to defend public interest remains uncertain, with the judge characterizing the outcome as a "toss-up."
  • Attorneys general might lack the resources to pursue litigation independently, potentially leading the court to appoint a special interest party.
  • There is uncertainty regarding the willingness of attorneys general to grant relator status to Musk due to his controversial profile.
  • OpenAI plans to raise capital by shifting the nonprofit foundation from a controlling position, though this may require altering its stated charitable purpose on paper.
  • The OpenAI board is reconsidering its position on outsized voting rights in response to public discussion and may adjust the conversion plan to mitigate legal risks.
  • Potential obstacles to the conversion include a finding of Musk's standing, appointment of a special interest party, or objections from attorneys general.
  • Proceeding with the current conversion plan without modification poses commercial risks, including potential embarrassment, damaged staff morale, fundraising difficulties, and investor hesitation.
  • Board members risk breach of fiduciary duty lawsuits if they proceed with the conversion before a court ruling, though they intend to rely on directors and officers liability insurance provided they are not found reckless.
  • The court's decision may ultimately depend on the empirical question of whether it serves the public interest for OpenAI to race first to produce artificial general intelligence.
  • The foundation may relinquish some control to secure capital but could face challenges in making controversial grants that conflict with the company's commercial interests.